Cdk7 Activators

Common Cdk7 Activators include, but are not limited to Retinoic Acid, all trans CAS 302-79-4, Curcumin CAS 458-37-7, Resveratrol CAS 501-36-0, (-)-Epigallocatechin Gallate CAS 989-51-5 and Genistein CAS 446-72-0.

Cdk7 activators comprise a group of compounds that enhance the activity of Cdk7 (Cyclin-dependent kinase 7). Cdk7 is a member of the cyclin-dependent kinase (CDK) family, a collection of serine/threonine kinases that play crucial roles in cell cycle progression, transcription regulation, and other cellular processes. Specifically, Cdk7 functions as a core component of the cyclin-activating kinase (CAK) complex, which also includes cyclin H and the assembly factor MAT1. Within this complex, Cdk7 is responsible for the phosphorylation of other CDKs, an essential step that activates these kinases and facilitates their role in driving cell cycle transitions.

The Cdk7 enzyme also serves a dual function as it is intimately involved in transcription regulation. It is a component of the transcription factor TFIIH complex, where it phosphorylates the C-terminal domain (CTD) of the largest subunit of RNA polymerase II. This phosphorylation event is a pivotal step in the transition from transcription initiation to elongation, ensuring the proper synthesis of mRNA. Cdk7 activators, by boosting the kinase activity of Cdk7, can influence both cell cycle progression and transcriptional processes. The precise modulation of Cdk7 activity using activators allows researchers to probe its functions in various cellular contexts, elucidating the intricate balance between cell proliferation and gene expression. Understanding the molecular interactions, specificity, and broader implications of Cdk7 activators is paramount for gaining insights into the multifaceted roles of CDKs in cellular dynamics and regulatory networks.